New York City-based biotechnology firm Definium Therapeutics has reached a pivotal juncture in the development of its flagship psychedelic candidate,…
Read More

New York City-based biotechnology firm Definium Therapeutics has reached a pivotal juncture in the development of its flagship psychedelic candidate,…
Read More
The landscape of modern drug development is currently undergoing a radical structural shift, characterized by an unprecedented explosion in the…
Read More
As the public health landscape enters 2025, medical professionals face a complex matrix of persistent and resurging infectious diseases across…
Read More
In the latest installment of This Week in Virology (TWiV), episode 1286, co-hosts Dr. Daniel Griffin and Vincent Racaniello deliver…
Read More
Public health infrastructure, scientific integrity, and evidence-based medicine have once again taken center stage as prominent virologists and clinical experts…
Read More
The latest installment of This Week in Virology (TWiV) has officially been released, bringing listeners comprehensive clinical insights from Dr.…
Read More
Public health infrastructure in the United States faces unprecedented challenges, according to a recent clinical update presented by Dr. Daniel…
Read More
The global landscape of regenerative medicine and cell therapy manufacturing has reached a significant operational milestone with the official introduction…
Read More
The pharmaceutical landscape for psychiatric care is currently witnessing a paradigm shift as New York City-based Definium Therapeutics advances its…
Read More
The landscape of clinical research is undergoing a seismic shift, characterized by a staggering escalation in data volume and the…
Read More